51 episodes

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empower patients and care partners at every step of their cancer journey.

Empowered‪!‬ Patient Empowerment Network

    • Health & Fitness
    • 5.0 • 1 Rating

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empower patients and care partners at every step of their cancer journey.

    Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

    Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

    Dr. Beth Faiman, a myeloma expert and researcher, discusses factors that should be considered when deciding to undergo CAR T-cell therapy, advice for preparing for and after the process, and why a good support team is essential. Dr. Faiman also shares research updates in CAR T-cell therapy, and alternatives options to this myeloma treatment.
    Dr. Beth Faiman is an Adult Nurse Practitioner in the department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic. Learn more about Dr. Faiman.
    See More From Thrive CAR T-Cell Therapy
    Download Resource Guide

    • 35 min
    HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape

    HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape

    Treatment options for multiple myeloma have increased substantially, mainly attributed to advancements in clinical trials. More than ever, HCPs having conversations about trials is critical. Given that underrepresented communities bear a disproportionate burden of multiple myeloma, it becomes imperative to shift this paradigm.
    What are the optimal approaches to initiate these conversations early in the patient journey? How should HCPs effectively communicate information about clinical trials to patients and their families, including care partners? Myeloma experts Dr. Craig Cole and Charise Gleason lend their expertise, offering insights into best practices and guidance on the next steps to be taken.
    Download Resource Guide  |  Descargar guía de recursos

    • 32 min
    HCP Roundtable: Best Practices for Talking About Clinical Trials With Myeloma Patients

    HCP Roundtable: Best Practices for Talking About Clinical Trials With Myeloma Patients

    Clinical trials represent tomorrow’s medicine today, yet not every patient confronting a myeloma diagnosis is informed about all available care options. Surprisingly, some patients and their care partners are never introduced to the possibility of participating in clinical trials. How can we alter the course? What strategies can healthcare professionals (HCPs) employ to effectively communicate information about clinical trials and guide patients through next steps?
    Experts Dr. Beth Faiman and RuthAnn Gordon share important insights into understanding the critical role of clinical trial nurses and how they educate and mentor nursing professionals around best practices for broaching clinical trial conversations.
    Download Resource Guide | Descargar guía de recursos
    See More from EPEP Myeloma

    • 28 min
    Follicular Lymphoma Patient Expert Q&A: Dr. Kami Maddocks

    Follicular Lymphoma Patient Expert Q&A: Dr. Kami Maddocks

    Follicular lymphoma expert, Dr. Kami Maddocks discusses the latest in follicular lymphoma, meaningful highlights from the American Society of Hematology 2023 meeting and answers questions submitted by patients and care partners.
    Dr. Maddocks is a hematologist/oncologist specializing in treating lymphatic diseases from The Ohio State University. 

    See More from START HERE Follicular Lymphoma
    Download Guide | Descargar Guía

    • 35 min
    Gastric Cancer: How to Access the Best Care and Treatment for YOU

    Gastric Cancer: How to Access the Best Care and Treatment for YOU

    Advances in gastric cancer research have led to more personalized therapy for patients. Dr. Yelena Janjigian discusses how biomarker testing can help guide a patient’s prognosis and treatment path, reviews currently available gastric cancer therapies, and shares tips for self-advocacy.
    Dr. Yelena Janjigian is Chief of Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. 
    See More From INSIST! Gastric Cancer
    Download Resource Guide

    • 30 min
    What Non-Small Cell Lung Cancer Treatment is Right for You?

    What Non-Small Cell Lung Cancer Treatment is Right for You?

    What’s the best approach for YOUR lung cancer? Dr. Isabel Preeshagul discusses the importance of engaging in your lung cancer care decisions, shares advice for working with your team to determine a treatment approach, and reviews factors that affect therapy options. Dr. Preeshagul also provides an update on the latest research and clinical trials.
    Dr. Isabel Preeshagul is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center. 
    Download Program Resource Guide
    See More From INSIST! Lung Cancer

    • 26 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
ZOE Science & Nutrition
ZOE
The School of Greatness
Lewis Howes
On Purpose with Jay Shetty
iHeartPodcasts
The Dr. John Delony Show
Ramsey Network
Passion Struck with John R. Miles
John R. Miles